Tom Foltynie

68PUBLICATIONS
198CO-AUTHORS
Molecular targetsEconometrics not elsewhere classifiedPredictive and prognostic markersPharmacogenomicsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|May 28, 2026
Observations on an Open-Label Phase 1/2 Dopamine Gene Therapy Trial (OXB-102/Axo-Lenti-PD) in People with Parkinson's Disease.

|May 23, 2026
Genetically proxied GLP1R expression does not predict exenatide response in the Exenatide-PD3 trial.

|May 07, 2026
Clinical prognostic indicators in multiple system atrophy.

|Mar 13, 2026
Levodopa Efficacy and GLP-1 Receptor Agonists.

Catherine Martinez, Christine Girges, Thomas Foltynie

|Mar 05, 2026
Peripheral and CSF protein quantification in Parkinson's disease and multiple system atrophy-the nucleic acid-linked immuno-sandwich assay.

Nirosen Vijiaratnam, Christine Girges, Arthur Mitchell

|Feb 24, 2026
Ambroxol for Parkinson's Disease.

Marco Toffoli, Elisa Menozzi, Kashfia Chowdhury

Pageof 12

Frequent Collaborators

12 joint publications

Huw R Morris

11 joint publications

Ludvic Zrinzo

7 joint publications

Nirosen Vijiaratnam

6 joint publications

Caroline Helen Williams-Gray